Partnership ProfileThis report describes and analyses the Stop TB Partnership, a Global Public-Private Initiative (GPPIs) for health. This report focuses on the role of private sector partners in the operations and governance of Stop TB. It does not evaluate outcomes or effectiveness in much detail, nor does it provide an analysis of each company’s approach to GPPIs for healthcare in general. This report forms part of a broader research project on the role of companies in public-private partnerships. Field studies on the implementation of the GPPIs in developing countries, conducted by partner organizations of WEMOS, form part of the broader research project. read more less
The European Alliance for Responsible Research & Development and Affordable Medicines (of which SOMO is a member) wrote a letter to the European Commission to express our concern about the next EU Health Private-Public Partnership….
In this joint statement, several civil society organisations have expressed their major concerns about the role of supplementary protection certificates (SPCs) in the accessibility and price of medicines in the Netherlands and elsewhere in Europe….
In the run-up to the general debate on Medicines policy on Thursday June 21st 2018, eight organizations in the Netherlands jointly sent a letter to the Dutch Parliament to inform them abouth their position concerning…